about
Complementary and alternative medicine treatments for children with autism spectrum disordersThe Impact of Neuroimmune Alterations in Autism Spectrum DisorderImmunologic and neurodevelopmental susceptibilities of autismCurrent progress and challenges in the search for autism biomarkersDifferential monocyte responses to TLR ligands in children with autism spectrum disorders.Aberrant immune responses in a mouse with behavioral disorders.Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with Autism Spectrum Disorder.The immune system's role in the biology of autism.Cerebral folate receptor autoantibodies in autism spectrum disorder.Perinatal stress, brain inflammation and risk of autism-review and proposal.Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study.Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomesParental autoimmune diseases associated with autism spectrum disorders in offspring.Environmental factors in autism.Autism spectrum disorder in children born preterm-role of exposure to perinatal inflammationAltered gene expression and function of peripheral blood natural killer cells in children with autism.Gestational exposure to a viral mimetic poly(i:C) results in long-lasting changes in mitochondrial function by leucocytes in the adult offspring.Increased anti-phospholipid antibodies in autism spectrum disorders.Increased IgG4 levels in children with autism disorder.Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability.Acetaminophen Use for Fever in Children Associated with Autism Spectrum DisorderImmune dysfunction in autism: a pathway to treatment.Autoimmune and gastrointestinal dysfunctions: does a subset of children with autism reveal a broader connection?Immune dysregulation in autism spectrum disorder.Brain autoantibodies in autism spectrum disorder.Autoimmunity, Autoantibodies, and Autism Spectrum Disorder.Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.Impaired downregulation of visual cortex during auditory processing is associated with autism symptomatology in children and adolescents with autism spectrum disorder.Autoantibodies to cerebellum in children with autism associate with behavior.Neonatal Cytokine Profiles Associated With Autism Spectrum Disorder.Aberrant IgG isotype generation in mice with abnormal behaviors.Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders.Autism spectrum disorders are associated with an elevated autoantibody response to tissue transglutaminase-2.HLA-class II haplotypes and Autism Spectrum Disorders.
P2860
Q22252305-41FF6655-7A02-4E85-BB2B-55A761A0FEA5Q26781540-5AE49AF4-D378-4899-AD41-43EBA19D23D1Q28275427-FEAC71BE-2698-4CBF-B1FC-44E0E0E7F7C9Q28680718-CA6469E8-ACA5-4733-9DB3-703574FA7B1EQ30477710-0A8170BC-3CC2-4EC4-8AF2-3C4D29E505E6Q31025723-63A5D8F4-9F58-4347-A64F-C9B29C54AC5EQ33952590-2991B762-744A-4D24-9DA1-6CD9506628C3Q33966312-BDDB72AA-A8E8-4B62-A889-18AE5A92D006Q34245893-FE72FE3D-6F01-47F8-9049-CB9548AF1750Q34285045-26835CF0-EA2E-40F2-805A-DE843735107BQ34788194-44E5FE56-2FFB-4BAB-AD28-9DD918798DB0Q34818778-9C6A4D7E-C78D-4FB4-89B1-C3EDCDB4BE9DQ35047183-6CE12DEA-390A-4E4F-B96A-54710B88F48CQ36542792-C4EB2193-C91D-4E7B-B1B1-72BCD958683AQ37030110-FB169235-52E0-4D40-B78F-AEB9D2FE59E1Q37085371-19C10526-1332-4C32-BA93-FB622033F9D9Q37221940-A7184967-6C8D-4472-B98D-BACDCC8DA2C7Q37224652-92378B1C-A693-493C-BC08-5D892BE9B6F2Q37227405-B1B676B9-169C-4CF0-83F5-32214D450E34Q37280911-AF0FAB28-6403-4215-BCA2-62F0D699F62CQ37300512-F6B9AA2A-9E74-4EEC-AA83-C9FB5FEABA03Q37774097-32036BE8-58DD-492E-8253-E5795DD61C03Q37903849-68CDEA77-8C7C-47B0-9507-2D17703E9BC8Q38168141-9C6D0AB1-AC3C-47EF-8211-8C7CEA9C7377Q38202987-B1C81A78-0A27-4C56-9DD7-EDC56AE23668Q39199499-75B416D4-5F25-42AD-A13C-2E8FA01F5EF9Q39411024-C0200CA7-E026-4044-83FE-866C3EB90289Q39749512-0E857121-B739-423E-A4AC-3E55199E1C7EQ39809070-03C1485E-80B8-4015-A4B8-47485EA85E68Q41337026-4FBCFBD5-6E18-49F5-B8E6-BF8B0996D626Q41409302-472D05D7-6EAB-40F5-B68B-53AAE94B11DEQ42855361-BC86FFD2-D4B0-463B-B018-738C39D1F7A5Q50311335-8209084B-6333-49F9-AC55-BD5D543D88C9Q54209528-F743E569-A7A6-4D57-9A3C-C35F56331854
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Autoantibodies in autism spectrum disorders (ASD)
@ast
Autoantibodies in autism spectrum disorders (ASD)
@en
Autoantibodies in autism spectrum disorders (ASD)
@nl
type
label
Autoantibodies in autism spectrum disorders (ASD)
@ast
Autoantibodies in autism spectrum disorders (ASD)
@en
Autoantibodies in autism spectrum disorders (ASD)
@nl
prefLabel
Autoantibodies in autism spectrum disorders (ASD)
@ast
Autoantibodies in autism spectrum disorders (ASD)
@en
Autoantibodies in autism spectrum disorders (ASD)
@nl
P2093
P2860
P921
P3181
P356
P1476
Autoantibodies in autism spectrum disorders (ASD)
@en
P2093
David Amaral
Jeff Bennett
Judy Van de Water
Maricel Cabanlit
Paul Ashwood
Sharifia Wills
P2860
P3181
P356
10.1196/ANNALS.1381.009
P407
P577
2007-06-01T00:00:00Z